1. Targeting apoptosis pathways in cancer with magnolol and honokiol, bioactive constituents of the bark of Magnolia officinalis
   Huanli Xu et al, 2011, Drug Discoveries & Therapeutics CrossRef
2. Heterocyclic Anti-cancer Compounds Derived from Natural Sources with their Mechanism of Action
   Sitesh C. Bachar et al, 2022, Key Heterocyclic Cores for Smart Anticancer Drug–Design Part I CrossRef
3. Magnolol protects PC12 cells from hydrogen peroxide or 6-hydroxydopamine induced cytotoxicity
   Takahito Nishiyama et al, 2019, The Journal of Toxicological Sciences CrossRef
4. Unveiling promising bioactives for breast cancer: a novel approach for herbal-based drug discovery
   Aditya Arvindekar et al, 2024, Phytochemistry Reviews CrossRef
5. The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor–induced apoptosis
   Shruti M. Raja et al, 2008, Molecular Cancer Therapeutics CrossRef
6. Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells
   Skolastika Skolastika et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
7. Honokiol Suppresses Survival Signals Mediated by Ras-Dependent Phospholipase D Activity in Human Cancer Cells
   Avalon Garcia et al, 2008, Clinical Cancer Research CrossRef
8. Honokiol Inhibits Proliferation, Invasion and Induces Apoptosis Through Targeting Lyn Kinase in Human Lung Adenocarcinoma Cells
   Xi Dai et al, 2018, Frontiers in Pharmacology CrossRef